# C4 Therapeutics, Inc.: Form 8-K/A, filed Jan 21, 2022

- Company: [C4 Therapeutics, Inc.](/companies/cccc.md) (CIK 1662579)
- Form: 8-K/A
- Filed: 2022-01-21
- Accepted by EDGAR: Jan 21, 2022, 16:12 ET
- Period: 2022-01-10
- Accession: 0001193125-22-014812
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1662579/000119312522014812/d296145d8ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1662579/000119312522014812/

## Items reported

- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1662579/000119312522014812/d296145d8ka.htm

Filed Jan 21, 2022.
Source: SEC EDGAR, the filing index for accession 0001193125-22-014812. Last ingested by Listed: Nov 5, 2026, 12:02 ET. No prices; not investment advice.